ClinicalTrials.Veeva

Menu

Coronary Artery Disease Severity in Newly Diagnosed Dysglycemia

S

Saud Al Babtain Cardiac Center

Status

Completed

Conditions

Coronary Artery Disease
Dysglycemia

Treatments

Radiation: Cardiac catheterization

Study type

Observational

Funder types

Other

Identifiers

NCT05210972
SBCC-IRB-2021-06

Details and patient eligibility

About

This cohort study will measure how severe is the coronary artery disease (CAD), at time of CAD diagnosis, clinically and angiographically in the different cohorts of newly diagnosed diabetes and prediabetes versus normal glycemia patients in the study center.

Enrollment

150 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All adult patients with consents.
  • First time diagnosis of CAD and no prior diagnosis of diabetes milletus (DM), or prediabetes.
  • Coronary artery disease confirmed by invasive coronary angiography.

Exclusion criteria

  1. Patients with known significant anemia, increased hemoglobin turnover, active hemoglobin drops or on erythropoietin therapy.
  2. Pregnant and post-partum patients (up to 3 months post-delivery).
  3. Patients with severe chronic renal failure (estimated glomerular filtration rate (eGFR) < 30 mL/min/1.72 m2).
  4. Patients on any medications with glucose lowering effects.

Trial design

150 participants in 3 patient groups

Diabetes
Description:
Patients with level of HbA1c ≥ 6.5%, or Fasting blood glucose (FBG) ≥126 mg/dL, or a random plasma glucose (RBG) ≥ 200 mg/dL in a patient with classic symptoms of hyperglycemia. In the absence of unequivocal hyperglycemia, diagnosis will be based on two abnormal test results, for FBG or RBG and HbA1c, from the same sample or in two separate test samples.
Treatment:
Radiation: Cardiac catheterization
Prediabetes
Description:
HbA1c 5.7-6.4% or FBG 110 mg/dL to 125 mg/dL The diagnosis will be based on two abnormal test results, for FBG or RBG and HbA1c, from the same sample or in two separate test samples.
Treatment:
Radiation: Cardiac catheterization
Normal glycemia
Description:
HbA1c \<5.7% and FBG 110 mg/dL
Treatment:
Radiation: Cardiac catheterization

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems